Patient-level integrated analysis of data from 6 randomized, double-blind, placebo-controlled trials of darbepoetin alfa (DA) in patients (pts) with chemotherapy-induced anemia (CIA)

被引：1
|
作者：
Ludwig, H. [1 ]
Crawford, J. [2 ]
Osterborg, A. [3 ]
Fleishman, A. [4 ]
Lillie, T. [4 ]
Sueto, T. [5 ]
Glaspy, J. [6 ]
机构：
[1] Wilhelminespital, Dept Med Oncol, Vienna, Austria
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Karolinska Univ Hosp, Stockholm, Sweden
[4] Amgen Inc, Thousand Oaks, CA USA
[5] Amgen GmbH, Int Med Affairs, Zug, Switzerland
[6] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70623-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1104
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [31] Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus ≥ 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled
    Vansteenkiste, Johan
    Hedenus, Michael
    Gascon, Pere
    Bokemeyer, Carsten
    Ludwig, Heinz
    Vermorken, Jan
    Hamilton, Lisa
    Bridges, Ken
    Pujol, Beatriz
    BMC CANCER, 2009, 9 : 311
  • [32] Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus ≥10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial
    Johan Vansteenkiste
    Michael Hedenus
    Pere Gascon
    Carsten Bokemeyer
    Heinz Ludwig
    Jan Vermorken
    Lisa Hamilton
    Ken Bridges
    Beatriz Pujol
    BMC Cancer, 9
  • [33] A phase 2, randomized, open-label study to assess the efficacy of extended dose schedule administration of darbepoetin alfa (DA) in cancer patients (pts) with chemotherapy-induced anemia (CIA).
    Schwartzberg, Lee
    Rearden, Timothy
    Yee, Lorrin
    Mirtsching, Barry
    Charu, Veena
    Lam, Hung
    Lillie, Tom
    Burkes, Ronald
    Silberstein, Peter
    BLOOD, 2006, 108 (11) : 382A - 383A
  • [34] A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL OF PENTOXIFYLLINE FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED ORAL MUCOSITIS
    VERDI, CJ
    GAREWAL, HS
    KOENIG, LM
    VAUGHN, B
    BURKHEAD, T
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1995, 80 (01): : 36 - 42
  • [35] Effect of darbepoetin alfa on physical function in patients undergoing surgery for colorectal cancer - A randomized, double-blind, placebo-controlled study
    Norager, C. B.
    Jensen, M. B.
    Madsen, M. R.
    Qvist, N.
    Laurberg, S.
    ONCOLOGY, 2006, 71 (3-4) : 212 - 220
  • [36] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY OF WEEKLY ADMINISTRATION OF DARBEPOETIN ALFA (DA) IN ANEMIC PATIENTS WITH LUNG OR GYNECOLOGIC CANCER RECEIVING PLATINUM-CONTAINING CHEMOTHERAPY
    Katakami, N.
    Nishiwaki, Y.
    Fujiwara, Y.
    Tsuboi, M.
    Takeda, K.
    Nakanishi, T.
    Ichinose, Y.
    Kawahara, M.
    Hotta, T.
    Saijo, N.
    ANNALS OF ONCOLOGY, 2008, 19 : 277 - 278
  • [37] Weekly Administration of Epoetin Beta for Chemotherapy-induced Anemia in Cancer Patients: Results of a Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Study
    Tsuboi, Masahiro
    Ezaki, Kohji
    Tobinai, Kensei
    Ohashi, Yasuo
    Saijo, Nagahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (03) : 163 - 168
  • [38] Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa on hemoglobin response and symptoms in patients with heart failure and anemia
    van Veldhuisen, DJ
    Dickstein, K
    Cohen-Solal, A
    Lok, DJA
    Wasserman, SM
    Baker, N
    Rosser, D
    Ponikowski, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 61A - 61A
  • [39] Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials
    Dao Thai-Cuarto
    Christopher F. O’Brien
    Roland Jimenez
    Grace S. Liang
    Joshua Burke
    Drug Safety, 2018, 41 : 429 - 440
  • [40] Double-blind placebo-controlled randomized clinical trial evaluating doxycycline effects on chemotherapy-induced oral mucositis
    Ramirez-Amador, V.
    Anaya-Saavedra, G.
    Labardini-Mendez, J.
    Ponce de Leon-Rosales, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (02) : 202 - 208
12345